GIACOMELLI, ROBERTO
 Distribuzione geografica
Continente #
NA - Nord America 1.348
EU - Europa 882
AS - Asia 255
OC - Oceania 30
SA - Sud America 27
AF - Africa 18
Totale 2.560
Nazione #
US - Stati Uniti d'America 1.282
GB - Regno Unito 544
IT - Italia 162
IN - India 105
CA - Canada 61
DE - Germania 51
FR - Francia 30
AU - Australia 29
JP - Giappone 27
TR - Turchia 21
HK - Hong Kong 18
CN - Cina 16
ES - Italia 16
PT - Portogallo 16
SG - Singapore 15
NL - Olanda 11
PL - Polonia 11
BR - Brasile 8
CL - Cile 8
EG - Egitto 8
AR - Argentina 7
IL - Israele 7
KZ - Kazakistan 7
SA - Arabia Saudita 6
GR - Grecia 5
MX - Messico 5
SK - Slovacchia (Repubblica Slovacca) 5
ZA - Sudafrica 5
CH - Svizzera 4
JO - Giordania 4
BG - Bulgaria 3
ID - Indonesia 3
IR - Iran 3
KW - Kuwait 3
LU - Lussemburgo 3
OM - Oman 3
PK - Pakistan 3
QA - Qatar 3
RO - Romania 3
RU - Federazione Russa 3
TH - Thailandia 3
BD - Bangladesh 2
BE - Belgio 2
EC - Ecuador 2
MA - Marocco 2
SE - Svezia 2
SI - Slovenia 2
TN - Tunisia 2
UA - Ucraina 2
AZ - Azerbaigian 1
BO - Bolivia 1
BY - Bielorussia 1
CO - Colombia 1
DK - Danimarca 1
HR - Croazia 1
HU - Ungheria 1
IQ - Iraq 1
KH - Cambogia 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MD - Moldavia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
RS - Serbia 1
TW - Taiwan 1
Totale 2.560
Città #
Ashburn 733
London 507
Council Bluffs 109
Pune 94
Boardman 91
San Francisco 70
Toronto 51
Washington 49
Seattle 42
Rome 40
West Jordan 20
Los Angeles 15
Tokyo 15
Singapore 14
Melbourne 12
Bari 11
Barcelos 10
Hanover 9
Sydney 9
Canberra 8
Naples 8
New York 8
Paris 7
Amsterdam 6
Warsaw 6
Andover 5
Berlin 5
Bratislava 5
Cairo 5
Central 5
Changsha 5
Oklahoma City 5
St Louis 5
Amman 4
Athens 4
Frankfurt am Main 4
Haikou 4
Manchester 4
Markham 4
Montreal 4
Noicattaro 4
Salerno 4
Secaucus 4
State College 4
Aberdeen 3
Almaty 3
Bangkok 3
Buenos Aires 3
Centurion 3
Charlotte 3
Chicago 3
Doha 3
Fiume Veneto 3
Gorle 3
Haifa 3
Kuwait City 3
Luxembourg 3
Machico 3
Madrid 3
Milan 3
Muscat 3
Newark 3
Riyadh 3
Sofia 3
Stillwater 3
São Paulo 3
Tel Aviv 3
Verona 3
West Lafayette 3
Alzano Lombardo 2
Anantapur 2
Ann Arbor 2
Barcelona 2
Bosco Marengo 2
Brest 2
Brussels 2
Buffalo 2
Cento 2
Cepagatti 2
Chiyoda-ku 2
Cleveland 2
Collazzone 2
Cuernavaca 2
Desio 2
Dhaka 2
Dyce 2
Edinburgh 2
Ercolano 2
Florence 2
Florencio Varela 2
Gauteng 2
Glasgow 2
Groningen 2
Herne Bay 2
Hyderabad 2
Islamabad 2
Kielce 2
L'aquila 2
La Jolla 2
Ljubljana 2
Totale 2.165
Nome #
SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients 40
------- 31
2-Arachidonoylglycerol Reduces the Production of Interferon-Gamma in T Lymphocytes from Patients with Systemic Lupus Erythematosus 29
Macrophage activation syndrome in patients affected by adult-onset still disease: Analysis of survival rates and predictive factors in the Gruppo Italiano di Ricerca in reumatologia clinica e sperimentale cohort 22
Interstitial lung disease in systemic sclerosis: Pathophysiology and therapy 22
The Vessels Contribute to Fibrosis in Systemic Sclerosis 21
Fibroblast expression of CD248 may contribute to exacerbate microvascular damage during systemic sclerosis 20
2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19 19
Recenti acquisizioni e orientamenti nel laboratorio di immunologia 15
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies 14
Linking myofibroblast generation and microvascular alteration: The role of CD248 from pathogenesis to therapeutic target (Review) 14
Interleukin-9 and T helper type 9 cells in rheumatic diseases 13
AB0458 A PHASE II RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF OF CONCEPT STUDY OF ORAL SELETALISIB IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME (PSS) 13
A comprehensive review on adult onset Still's disease 13
Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational study 13
Benefits of anakinra versus TNF inhibitors in rheumatoid arthritis and type 2 diabetes: long-term findings from participants furtherly followed-up in the TRACK study, a multicentre, open-label, randomised, controlled trial 13
Duration of clinical remission and low disease activity impacts on quality of life and its domains in psoriatic arthritis patients: results from an Italian multicentre study 13
Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implications 12
Diagnosis of COVID-19 associated arthritis in patients with or without underlying rheumatic and musculoskeletal disease supported by musculoskeletal ultrasound: a case series from three European centres 11
Clinical, Epidemiological, and Histopathological Features of Respiratory Involvement in Rheumatoid Arthritis 11
Adult-onset Still's disease with elderly onset: results from a multicentre study 11
The economic burden of fibromyalgia: A systematic literature review 11
Methotrexate in rheumatoid arthritis: optimizing therapy among different formulations. Current and emerging paradigms 11
Drug interaction between cyclosporin A and nizatidine in Sprague-Dawley rats. 11
Laboratory assessment in patients with suspected rheumatic musculoskeletal diseases: challenges, pitfalls and perspectives 11
). IL-6 e TGF-b1 nel siero e nei sovranatanti di cellule mononucleate in pazienti con sclerosi sistemica (SSC). 11
Il Laboratorio nelle malattie autoimmuni sistemiche 11
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 11
Prevalence and characteristics of diffuse idiopathic skeletal hyperostosis (DISH) in Italy 10
Heterogeneity of epitopes of the CD4 molecule in a female patient with idiopathic pulmonary fibrosis 10
Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. 10
Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study 10
EULAR Textbook on Rheumatic Diseases – Third Edition (2018) 10
Neurological Involvement in a Cohort of Primary Sjogren's Syndrome Patients: Results of a Multicenter Italian Study 10
Association Between Minor Salivary Gland Biopsy During Sjӧgren's Syndrome and Serologic Biomarkers: A Systematic Review and Meta-Analysis 10
Response to: 'Correspondence on 'Changing the outcome measures, changing the results? The urgent need of a specific disease activity score to adult-onset Still's disease'' by Muraviov and Muraviova 9
Expanding the spectrum of the hyperferritinemic syndrome, from pathogenic mechanisms to clinical observations, and therapeutic implications 9
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6 9
Immunomodulating activity of famotidine and nizatidine. 9
Intravenous N-acetylcysteine for treatment of Raynaud's phenomenon secondary to systemic sclerosis: a pilot study 9
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling 9
Response to Interleukin-1 Inhibitors in 140 Italian Patients With Adult-Onset Still's Disease: A Multicentre Retrospective Observational Study 9
Gamma-Delta T lymphocytes in HIV-infected patients 9
Long-term retention rate of anakinra in adult onset Still’s disease and predictive factors for treatment response 9
PTP4A1 promotes TGFβ signaling and fibrosis in systemic sclerosis 9
Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still's disease 9
Long-term Safety of Rituximab in Primary Sjögren Syndrome: The Experience of a Single Center 9
Beyond the joints, the extra-articular manifestations in rheumatoid arthritis 9
Addressing the clinical unmet needs in primary Sjögren's Syndrome through the sharing, harmonization and federated analysis of 21 European cohorts 9
Dissecting the clinical heterogeneity of adult-onset Still's disease: results from a multi-dimensional characterization and stratification 9
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases 9
The negative impact of pain catastrophising on disease activity: analyses of data derived from patient-reported outcomes in psoriatic arthritis and axial spondyloarthritis 8
Correction to: Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 8
Multicenter Validation of the DETAIL Questionnaire for the Screening of Spondyloarthritis in Patients With Inflammatory Bowel Diseases 8
Early Spondyloarthritis Clinic: Organizational Improvements in the Patient Journey 8
Novel biomarker for pulmonary vascular disease in systemic sclerosis patients 8
Macrophages with regulatory functions, a possible new therapeutic perspective in autoimmune diseases 8
Natural killer activity and antibody-dependent cellular cytotoxicity in progressive systemic sclerosis 8
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 8
Vasculiti renali: revisione della letteratura e descrizione di un caso clinico 8
Stromal Cell-derived Factor 1 in Cardiac and Autoimmune Disease 8
Rituximab modulates the expression of IL-22 in the salivary glands of patients with primary Sjogren's syndrome. 8
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 8
H-ferritin and CD68(+) /H-ferritin(+) monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease 8
Different operators and histologic techniques in the assessment of germinal center-like structures in primary Sjögren's syndrome minor salivary glands 8
Ferritin and C-reactive protein are predictive biomarkers of mortality and macrophage activation syndrome in adult onset Still's disease. Analysis of the multicentre Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort 8
Mesenchymal stem cells transplantation in Systemic Sclerosis: comment on the article by ATJ Maria et al 8
ASSOCIATION OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR (UPAR) GENE VARIANT WITH THE VASCULAR COMPLICATIONS OF SYSTEMIC SCLEROSIS 8
L'ITS riduce i livelli sierici di CD30 solubile (sCD30) in pazienti con allergia a veleno d' ape 8
LONG-TERM ANTI-TNF THERAPY AND RISK OF SERIOUS INFECTIONS IN A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS: COMPARISON AMONG ADALIMUMAB, ETANERCEPT AND INFLIXIMAB. ANNALS OF THE RHEUMATIC DISEASES 8
Where are we going in the management of interstitial lung disease in patients with systemic sclerosis? 8
Linfociti T Gamma-Delta (G/D) in pazienti con malattie infiammatorie intestinali (IBD) 8
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 8
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 8
The clinical heterogeneity of adult onset Still's disease may underlie different pathogenic mechanisms. Implications for a personalised therapeutic management of these patients 7
Possible role for IL-40 and IL-40-producing cells in the lymphocytic infiltrated salivary glands of patients with primary Sjögren's syndrome 7
Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis 7
The similar expression of both ferritin and scavenger receptors activation genes in patients with COVID19 and AOSD support their role in the pathogenesis of these diseases and identify a common mechanism at the basis of the "hyperferritinemic syndromes" 7
Development and Implementation of the AIDA International Registry for Patients With VEXAS Syndrome 7
Cytokines in the pathogenesis of rheumatoid arthritis: new players and therapeutic targets 7
T helper 1 response is correlated with widespread pain, fatigue, sleeping disorders and the quality of life in patients with fibromyalgia and is modulated by hyperbaric oxygen therapy 7
IL-9 over-expression and Th9 polarization in Systemic Sclerosis patients 7
Severe COVID-19 and related hyperferritinaemia: more than an innocent bystander? 7
Biologic Drugs in Adult Onset Still's Disease: A Systematic Review and Meta-Analysis of Observational Studies 7
Imbalance of immune functions in progressive systemic sclerosis patients 7
l'immunoterapia dei tumori 7
Alterazioni immunologiche in corso di malattie infiammatorie intestinali. 7
Damage of cutaneous peripheral nervous system evolves differently according to the disease phase and subset of systemic sclerosis 7
Impaired Cav-1 expression in SSc mesenchymal cells upregulates VEGF signaling: a link between vascular involvement and fibrosis 7
The role of innate and lymphoid IL-22-producing cells in the immunopathology of primary Sjögren's syndrome. 7
Subclinical and clinical atherosclerosis in rheumatoid arthritis: results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 7
Pathogenesis of adult onset still’s disease: current understanding and new insights 7
Is minor salivary gland biopsy more than a diagnostic tool in primary Sjo¨gren׳s syndrome? Association between clinical, histopathological, and molecular features: A retrospective study 7
Myositis in primary Sjögren's syndrome: data from a multicentre cohort. 7
Cardiovascular disease in primary sjögren’s syndrome 7
Pro-inflammatory CX3CR1+ CD59+ TL1A+ IL-23+ monocytes are expanded in patients with Ankylosing Spondylitis and modulate ILC3 immune functions 7
Aberrant cytokine expression and severity of the infiltrates are reverted by rituximab therapy in salivary glands of patients with Sjogren’s syndrome 7
Interstitial lung disease in systemic sclerosis: current and future treatment. 7
EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR) 7
The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis 7
Totale 1.027
Categoria #
all - tutte 85.581
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.581


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022648 0 5 29 4 7 2 4 4 55 29 19 490
2022/2023318 5 15 11 28 73 13 6 7 10 11 130 9
2023/20241.696 60 216 61 144 198 839 32 85 17 44 0 0
Totale 2.662